© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
May 04, 2022
Fecal microbiota transplantation is proving to be an effective treatment for many patients with specific disorders associated with dysbiosis.
September 07, 2021
From an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
May 11, 2021
Approximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.